FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 03:44:54 2024-05-22 pm EDT | ||
| 4.1 EUR | +23.12% |
|
| Current month | -45.98% | ||
| 1 month | -84.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 4.1 | +23.12% |
| 24-05-21 | 3.33 | -1.48% |
| 24-05-20 | 3.38 | -3.15% |
| 24-05-17 | 3.49 | +1.75% |
| 24-05-16 | 3.43 | +7.52% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 03:44 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4G0G |
| ISIN | DE000JK4G0G1 |
| Date issued | 2024-03-22 |
| Strike | 256.2 $ |
| Maturity | Unlimited |
| Parity | 7.41 : 1 |
| Emission price | 10.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 30.45 € |
|---|---|
| Lowest since issue | 2.88 € |
| Spread | 0.3 € |
| Spread % | 6.88% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
